LCTX vs GILD: Which Stock is Better?

Side-by-side comparison of Lineage Cell Therapeutics Inc and Gilead Sciences Inc in 2026

Comparison Updated:

LCTX

Lineage Cell Therapeutics Inc

$1.71

GILD

Gilead Sciences Inc

$137.64

Key Metrics Comparison

MetricLCTXGILDWinner
Market Cap$408.50M$171.97BGILD
P/E RatioN/A20.44GILD
EPS (TTM)$N/A$6.78GILD
Revenue Growth1.3%0.0%LCTX
Gross Margin-22.8%78.8%GILD

Analyze LCTX

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LCTX or GILD a better investment?

Comparing LCTX and GILD: Lineage Cell Therapeutics Inc has a market cap of $408.50M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LCTX and GILD?

LCTX (Lineage Cell Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LCTX or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: LCTX or GILD?

LCTX has higher revenue growth at 1.3% vs 0.0% for GILD.

Which company is more profitable: LCTX or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -22.8% for LCTX.

Which is the larger company: LCTX or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $408.50M for LCTX.

Should I buy LCTX or GILD in 2026?

Both LCTX and GILD have investment merit. LCTX trades at $1.71 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LCTX and GILD stock?

Key differences: Market Cap ($408.50M vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (1.3% vs 0.0%), Gross Margin (-22.8% vs 78.8%).

Popular Stock Comparisons